Shengyong Geng
- Biomaterials top 10%
- Pharmaceutical Science top 10%
- Advancements in Transdermal Drug Delivery 3
- Biomedical Engineering top 10%
- Nanoplatforms for cancer theranostics 14
-
- MXene and MAX Phase Materials 6
- Advanced Nanomaterials in Catalysis 6
- 2D Materials and Applications 5
-
- Extracellular vesicles in disease 6
- Advanced biosensing and bioanalysis techniques 5
- RNA Interference and Gene Delivery 3
Shengyong Geng
28 papers receiving 577 citations
Peers
Comparison fields: 5 of 89
- Biomaterials 119
- Pharmaceutical Science 53
- Biomedical Engineering 290
- Materials Chemistry 255
- Dermatology 25
Countries citing papers authored by Shengyong Geng
This map shows the geographic impact of Shengyong Geng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengyong Geng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengyong Geng more than expected).
Fields of papers citing papers by Shengyong Geng
This network shows the impact of papers produced by Shengyong Geng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengyong Geng. The network helps show where Shengyong Geng may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shengyong Geng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 10 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 4 | |
| 4 | 2024 | 11 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 2 | |
| 7 | 2023 | 17 | |
| 8 | 2023 | 6 | |
| 9 | 2023 | 7 | |
| 10 | 2023 | 23 | |
| 11 | 2023 | 16 | |
| 12 | 2023 | 1 | |
| 13 | 2022 | 14 | |
| 14 | 2020 | 39 | |
| 15 | 2020 | 8 | |
| 16 | 2018 | 56 | |
| 17 | 2014 | 38 | |
| 18 | 2013 | 15 | |
| 19 | 2013 | 13 | |
| 20 | 2013 | 3 |
About Shengyong Geng
Shengyong Geng is a scholar working on Pharmaceutical Science, Materials Chemistry and Biomedical Engineering, having authored 29 papers that have together received 584 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (14 papers), Extracellular vesicles in disease (6 papers), MXene and MAX Phase Materials (6 papers), Advanced Nanomaterials in Catalysis (6 papers), 2D Materials and Applications (5 papers), Advanced biosensing and bioanalysis techniques (5 papers), Advancements in Transdermal Drug Delivery (3 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Biomaterials (119 citations), Pharmaceutical Science (53 citations) and Biomedical Engineering (290 citations). Shengyong Geng has collaborated with scholars based in China, Hong Kong and Japan. Frequent co-authors include Xue‐Feng Yu, Paul K. Chu, Jin‐Ye Wang, Wenhua Zhou, Zhibin Li, Haodong Cui, Lie Wu, Geng Qin, Satoshi Wada and Guanghong Luo. Their work appears in journals such as Biosensors and Bioelectronics, Journal of Nanobiotechnology, Chemical Engineering Journal, Advanced Functional Materials and Journal of Colloid and Interface Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.